Genprex Inc. is a biotech company based in Austin, TX, specializing in pioneering gene therapies for patients with cancer and diabetes. Their innovative technologies aim to administer disease-fighting genes, providing new treatment options for large patient populations who currently have limited choices. With a strong pipeline of gene therapies, including their lead product candidate, Reqorsa Immunogene Therapy, Genprex is committed to developing life-changing therapies to effectively treat these diseases.
Genprex's multidisciplinary management team, consisting of executives and advisors with extensive experience in the biotech and pharmaceutical industries, as well as research and clinical expertise from renowned medical and academic institutions worldwide, ensures a combination of expertise and innovation in their research efforts. Dedicated to helping patients with limited or no treatment options, Genprex strives to provide access to advanced therapies that can significantly impact the lives of those affected by cancer and diabetes.
Generated from the website